{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:51:06Z","timestamp":1760982666402},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00595-007-3686-2","type":"journal-article","created":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T11:20:29Z","timestamp":1215516029000},"page":"585-591","source":"Crossref","is-referenced-by-count":22,"title":["Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer"],"prefix":"10.1007","volume":"38","author":[{"given":"Masato","family":"Hino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,9]]},"reference":[{"key":"3686_CR1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1200\/JCO.2002.20.6.1456","volume":"20","author":"I.C. Smith","year":"2002","unstructured":"Smith IC, Heys SD, Hutcheon AW. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 2002;20:1456\u20131466.","journal-title":"J Clin Oncol"},{"key":"3686_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2003.18.114","volume":"21","author":"H.D. Bear","year":"2003","unstructured":"Bear HD, Anderson S, Brown A. The effect on tumor response of adding sequential preoperative docetaxcel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project B-27. J Clin Oncol 2003;21:1\u201310.","journal-title":"J Clin Oncol"},{"key":"3686_CR3","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.1999.17.11.3412","volume":"17","author":"A.U. Buzder","year":"1999","unstructured":"Buzder AU, Singletary ES, Theriault RL. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. J Clin Oncol 1999;17: 3412\u20133417.","journal-title":"J Clin Oncol"},{"key":"3686_CR4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.10741","volume":"95","author":"E.R. Fisher","year":"2002","unstructured":"Fisher ER, Wang J, Bryant J. Pathobiology of preoperative chemotherapy findings from National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-18. Cancer 2002;95:681\u2013695.","journal-title":"Cancer"},{"key":"3686_CR5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/JCO.2002.20.5.1304","volume":"20","author":"R. Rouzier","year":"2002","unstructured":"Rouzier R, Extra JM, Klijanienko J. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 2002;20:1304\u20131310.","journal-title":"J Clin Oncol"},{"key":"3686_CR6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.1999.17.2.460","volume":"17","author":"H.M. Kuerer","year":"1999","unstructured":"Kuerer HM, Newman LA, Smith TL. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 1999;17:460\u2013469.","journal-title":"J Clin Oncol"},{"key":"3686_CR7","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12B+<2776::AID-CNCR25>3.0.CO;2-V","volume":"83","author":"J.A. Petrek","year":"1997","unstructured":"Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1997;83:2776\u20132781.","journal-title":"Cancer"},{"key":"3686_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.1999.17.1.143","volume":"17","author":"T.F. Hack","year":"1999","unstructured":"Hack TF, Cohen L, Katz J. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999;17:143\u2013149.","journal-title":"J Clin Oncol"},{"key":"3686_CR9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B. Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002;347:567\u2013574.","journal-title":"N Engl J Med"},{"key":"3686_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10434-999-0109-1","volume":"6","author":"R.K. Orr","year":"1999","unstructured":"Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival \u2014 a Bayesian meta-analysis. Ann Surg Oncol 1999;6:109\u2013116.","journal-title":"Ann Surg Oncol"},{"key":"3686_CR11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U. Veronesi","year":"2003","unstructured":"Veronesi U, Pagenelli G, Luini A. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546\u2013553.","journal-title":"N Engl J Med"},{"key":"3686_CR12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199810013391401","volume":"339","author":"D. Krag","year":"1998","unstructured":"Krag D, Weaver D, Ashikaga A. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339: 941\u2013946.","journal-title":"N Engl J Med"},{"key":"3686_CR13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"A.E. Giuliano","year":"1994","unstructured":"Giuliano AE, Kirgan DM, Guenther JM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220: 391\u2013401.","journal-title":"Ann Surg"},{"key":"3686_CR14","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","volume":"349","author":"U. Veronesi","year":"1997","unstructured":"Veronesi U, Paganelli G, Galimberti V. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864\u20131867.","journal-title":"Lancet"},{"key":"3686_CR15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00000658-199805000-00005","volume":"227","author":"C.E. Cox","year":"1998","unstructured":"Cox CE, Pendas S, Cox J. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645\u2013653.","journal-title":"Ann Surg"},{"key":"3686_CR16","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","volume":"349","author":"U. Veronesi","year":"1997","unstructured":"Veronesi U, Paganelli G, Galimberti A. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864\u20131867.","journal-title":"Lancet"},{"key":"3686_CR17","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1200\/JCO.2000.18.13.2560","volume":"18","author":"K.M. McMaster","year":"2000","unstructured":"McMaster KM, Tuttle TM, Carlson DJ. Sentinel Lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560\u20132566.","journal-title":"J Clin Oncol"},{"key":"3686_CR18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00000658-199906000-00013","volume":"229","author":"V.S. Kimberg","year":"1999","unstructured":"Kimberg VS, Rubio IT, Henry R. Subareolar versus pertumoral injection for location of the sentinel lymph node. Ann Surg 1999; 229:860\u2013865.","journal-title":"Ann Surg"},{"key":"3686_CR19","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.1997.15.6.2345","volume":"15","author":"A. Giuliano","year":"1997","unstructured":"Giuliano A, Jones RC, Brennan M. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345\u20132350.","journal-title":"J Clin Oncol"},{"key":"3686_CR20","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1200\/JCO.2000.18.20.3480","volume":"18","author":"T.M. Breslin","year":"2000","unstructured":"Breslin TM, Cohen L, Sahin A. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000;18:3480\u20133486.","journal-title":"J Clin Oncol"},{"key":"3686_CR21","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/1097-0142(20001201)89:11<2187::AID-CNCR6>3.0.CO;2-#","volume":"89","author":"K.S. Nason","year":"2000","unstructured":"Nason KS, Anderson BO, Byrd DR. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000;89:2187\u20132194.","journal-title":"Cancer"},{"key":"3686_CR22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9610(01)00736-X","volume":"182","author":"T.B. Julian","year":"2001","unstructured":"Julian TB, Patel N, Olsen P. Sentinel lymph node biopsy after neoadjuvant for breast cancer. Am J Surg 2001;182:407\u2013410.","journal-title":"Am J Surg"},{"key":"3686_CR23","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/1097-0142(20010901)92:5<1080::AID-CNCR1423>3.0.CO;2-1","volume":"92","author":"A. Haid","year":"2001","unstructured":"Haid A, Tausch C, Lang A. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001;92:1080\u20131084.","journal-title":"Cancer"},{"key":"3686_CR24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/ejso.2002.1349","volume":"29","author":"J.R.M. Piato","year":"2002","unstructured":"Piato JRM, Pincerato KM, Pinotti JA. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. EJSO 2002;29:118\u2013120.","journal-title":"EJSO"},{"key":"3686_CR25","first-page":"71a","volume":"18","author":"K. Dookeran","year":"1999","unstructured":"Dookeran K, Zaren H. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Proc Am Soc Clin Oncol 1999;18(abstr 269):71a.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"3686_CR26","first-page":"71a","volume":"18","author":"B. Anderson","year":"1999","unstructured":"Anderson B, Jewell K, Eary J. Neoadjuvant chemotherapy contraindicates sentinel node mapping in breast cancer. Proc Am Soc Clin Oncol 1999;18(abstr 268):71a.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"3686_CR27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P. Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer A. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205\u2013216.","journal-title":"J Natl Cancer Inst"},{"key":"3686_CR28","volume-title":"Obesity: preventing and managing the global epidemic","author":"World Health Organization.","year":"1998","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: WHO; 1998."},{"key":"3686_CR29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/91.4.368","volume":"91","author":"U. Veronesi","year":"1999","unstructured":"Veronesi U, Paganelli G, Viale G. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368\u2013373.","journal-title":"J Natl Cancer Inst"},{"key":"3686_CR30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02967992","volume":"11","author":"M. Sano","year":"2004","unstructured":"Sano M. Minimally invasive treatment for patients with early breast cancer. Breast Cancer 2004;11:2\u20136.","journal-title":"Breast Cancer"},{"key":"3686_CR31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/bjc.1997.392","volume":"76","author":"M.T. Seymour","year":"1997","unstructured":"Seymour MT, Moskovic EC, Walsh G. Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer. Br J Cancer 1997;76:371\u2013376.","journal-title":"Br J Cancer"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-007-3686-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-007-3686-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-007-3686-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T03:45:58Z","timestamp":1559101558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-007-3686-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["3686"],"URL":"https:\/\/doi.org\/10.1007\/s00595-007-3686-2","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}